Normothermic Machine Perfusion Market Analysis Highlights Growth To $3.11 Billion By 2030 At 16% CAGR

The normothermic machine perfusion market is poised for significant expansion as technological advancements and growing demand for organ transplantation drive its development. Innovations in device portability and integration with smart systems are shaping the future of this vital medical field. Let's explore the market size, key players, emerging trends, and segment dynamics that define the trajectory of normothermic machine perfusion.

Impressive Growth Projections for the Normothermic Machine Perfusion Market
The market for normothermic machine perfusion is expected to experience rapid growth, reaching a valuation of $3.12 billion by 2030. This represents a strong compound annual growth rate (CAGR) of 16.0%. Several factors contribute to this expansion, including the introduction of portable and battery-powered devices, advancements in mechanical circulation and oxygenation technologies, and the rising global demand for organ transplants. Moreover, the growing integration of smart monitoring systems and ongoing research and development efforts in organ preservation further boost market momentum. Key trends anticipated during this period involve increased adoption of portable normothermic devices, enhanced focus on organ viability and prolonged preservation, incorporation of cutting-edge monitoring technologies, expansion of transplantation programs, and broader use in research applications.

Download a free sample of the Normothermic Machine Perfusion market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24341&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Top Companies Leading the Normothermic Machine Perfusion Industry
Several prominent companies are at the forefront of the normothermic machine perfusion market. These include TransMedics Inc., OrganOx Limited, XVIVO Perfusion AB, Organ Recovery Systems Inc., Bridge to Life Ltd., Paragonix Technologies Inc., Lifeline Scientific Inc., LifePort Inc., XENIOS AG, Lung Bioengineering Inc., Waters Medical Systems LLC, Organ Assist B.V., Preservation Solutions Inc., Perfusix AB, Fluent Medical Inc., HemoTherapeutics Inc., Revivicor Inc., Transplant Solutions Inc., BioMedica Diagnostics (Organ Perfusion Division), Advanced Perfusion Systems Inc., Organ Preservation Alliance Technologies, and NormaTech Medical Systems. These organizations contribute significantly to innovation, product development, and expanding the reach of normothermic machine perfusion solutions worldwide.

Strategic Partnerships Enhancing Organ Transplant Solutions
In March 2025, a notable collaboration took place between OrganOx Limited, a UK-based medical device manufacturer, and Procure On Demand Ltd., a US healthcare company specializing in human organ transplantation. This partnership combines OrganOx's normothermic machine perfusion system with Procure On Demand's skilled surgical teams and extensive national service network. The alliance aims to provide flexible, comprehensive solutions tailored to the needs of transplant centers, ultimately improving both transplant efficiency and patient outcomes by streamlining donor liver recovery and assessment processes.

View the full Normothermic Machine Perfusion market report:
https://www.thebusinessresearchcompany.com/report/normothermic-machine-perfusion-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Research Facilities Fueling Innovation in Normothermic Perfusion
Leading market players are actively investing in advanced research centers to accelerate technological innovations and improve transplant success rates. Expanding these facilities enhances capacity for organ preservation, clinical research, and practical applications, thereby contributing to better transplant availability and outcomes. For example, in May 2024, OrganOx Ltd. opened a new 18,000-square-foot global research, development, and production hub in Oxford. This move follows the success of its Metra device, which has markedly improved liver transplant results globally. The new facility underscores the company's commitment to advancing scientific and clinical breakthroughs through technology aimed at treating organ failure more effectively.

Key Segments Influencing Normothermic Machine Perfusion Market Expansion
This market is segmented based on product type, technology, application, and end-user categories. Product types include Portable Normothermic Machines and Stationary Normothermic Machines, with further distinctions such as compact portable units, battery-operated portable devices, and transport-friendly models under portable machines. Stationary options are classified as in-hospital stationary machines, modular stationary systems, and advanced fixed-location units. Technology segments cover mechanical circulation, oxygenation, and monitoring technologies. Applications are divided into organ preservation, organ transplantation, and research and development. End-users include hospitals and ambulatory surgery centers (ASCs), specialty clinics, and other healthcare facilities. These segments collectively provide a comprehensive overview of the factors driving growth and specialization within the normothermic machine perfusion market.

Key enhancements in our 2026 market reports include:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.